Menges, Slovenia

Darja Obrstar

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Lek Pharmaceuticals D.d.. Active years: 2016.


% Patents Active = 100.0

 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Darja Obrstar

Introduction

Darja Obrstar is a notable inventor based in Menges, Slovenia. She has made significant contributions to the field of biotechnology, particularly in the development of methods for selecting high-yielding cell lines for recombinant protein production. Her work is essential for advancing biopharmaceutical manufacturing processes.

Latest Patents

Darja Obrstar holds a patent titled "Selection of triploid CHO cells and cell lines expressing recombinant polypeptides as high producers." This invention relates to a method for selecting cells or cell lines that produce recombinant proteins or polypeptides in high yields. The method allows for the early selection of high producer cells or cell lines during development. It involves determining the nuclear DNA content of the cells or cell lines, which positively correlates with their capacity to produce the desired recombinant protein or polypeptide. She has 1 patent to her name.

Career Highlights

Darja Obrstar is currently associated with Lek Pharmaceuticals D.d., a prominent company in the pharmaceutical industry. Her role involves leveraging her expertise in biotechnology to enhance the efficiency of drug production processes. Her innovative approach has positioned her as a valuable asset in her field.

Collaborations

[This section has been skipped due to space constraints.]

Conclusion

Darja Obrstar's contributions to biotechnology through her innovative patent demonstrate her commitment to advancing the field. Her work not only enhances the efficiency of recombinant protein production but also showcases the importance of scientific innovation in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…